Insiders · KYNB

KYNB insider transactions

Kyntra Bio Inc. (KYNB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KYNB

• 31d
  SEC Form 4 filed by Director Ho Maykin

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 31d
  SEC Form 4 filed by Director Edwards Jeffrey L

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 31d
  SEC Form 4 filed by Director Kauffman Michael

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 31d
  SEC Form 4 filed by Director Schoeneck James A

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 39d
  CEO Wettig Thane covered exercise/tax liability with 198 shares, decreasing direct ownership by 0.73% to 27,005 units (SEC Form 4)

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 39d
  Chief Financial Officer Delucia David covered exercise/tax liability with 52 shares, decreasing direct ownership by 1% to 4,377 units (SEC Form 4)

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 60d
  Amendment: CEO Wettig Thane bought $19,852 worth of shares (2,800 units at $7.09), increasing direct ownership by 11% to 27,203 units (SEC Form 4)

  4/A - KYNTRA BIO, INC. (0000921299) (Issuer)
• 61d
  CEO Wettig Thane decreased direct ownership by 9% to 27,203 units (SEC Form 4)

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 130d
  SEC Form 4 filed by Kyntra Bio Inc.

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 130d
  SEC Form 4 filed by Kyntra Bio Inc.

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 163d
  SEC Form 4 filed by CEO Wettig Thane

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 163d
  SEC Form 4 filed by Chief Financial Officer Delucia David

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)